- Bioextrax Raises About SEK 6 Million in Private Placement
- BUZZ-NextDecade shares surge as the US Federal Energy Regulatory Commission (FERC) approves increased capacity for the Rio Grande LNG project and the company announces quarterly profits.
- The US Department of Defense awards the Future Interceptor contract to Lockheed Martin
- Peoples Declares 5% Stock Dividend
- BioMarin Signs License Deal for Fabry Disease Therapy Candidate
- Curtiss-Wright to Invest $30 Million in Texas Facility Expansion
- Franklin Templeton Launches Two ETFs Combining U.S. Equities and Bitcoin
- F&M Bank Q3 2026 net income falls 51% quarter-on-quarter to $2.64 million
- US Stock Movement | Rumors of Acquisition of Lumentum, Marvell Technology (MRVL.US) Drops Over 12%
- Fondo Alpha Immobiliare Announces Availability of Interim Management Report for Period Ended Sept. 30, 2026
- BUZZ - Thrive, owned by Josh Kushner, will acquire ADT for $7.6 billions, causing the stock price to surge
- Updated Version 2 - Correction - Bristol Myers Squibb Raises 2026 Revenue Forecast, Lowers Earnings Per Share Outlook Due to Provision for Expenses
- BUZZ-Insmed shares rise as revenue forecasts are raised
- BUZZ - Thrive, owned by Josh Kushner, will acquire ADT for $7.6 billion, shares surge
- Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
- UBS Adjusts Price Target on Wingstop to $150 From $140, Maintains Neutral Rating
- The euro fell to 0.8347 against the British pound, approaching a 19-month low.
- Gold Orogen identifies 4 km by 2 km gold-tungsten-antimony soil anomaly at Riley Brook
- Telmes wins extension lifting Calabria hydrogen plant contract to about EUR 2 million
- Sheffield Green Holds Annual General Meeting
- California's Billionaire Wealth Tax Is a -2-
- SouthGobi Resources Postpones Special Shareholder Meeting to Dec. 17, 2026
- Garrett Motion Shares Rise After Q3 Earnings, Net Sales Climb
- Megalestari Epack Seeks Shareholder Approval for Rights Issue of Up to 2 Billion Shares
- CROCS, INC. <CROX.O>: NEEDHAM RAISES TARGET PRICE TO $190 FROM $150
- Insperity Shares Fall After Q3 Results, Updated 2026 Adjusted Earnings Guidance
- The agentic economy: Why AI agents need a different kind of payment rail
- Bitcoin and physical gold under one roof: A diversification case study
- Wealth in retirement: A use case for Bitcoin in IRAs
- PBF Energy intensifies refinery improvements, aiming for cost savings exceeding 350 million dollars.
- Novavax Earns $125 Million Milestone Payment From Sanofi's Phase 3 Vaccine Trial in Europe
- U.S. Stock Market Movement: Universal Display Plunges on October 29—Revenue Misses Expectations, Material Sales Drop, Guidance at Lower End
- SentinelOne to Add Anthropic's Claude Mythos 5.1 to Wayfinder Frontier AI Services
- --Atlanta Fed Initial US Q4 GDP Nowcast Estimate 3.2% Gain
- Textron Up Over 12%, on Pace for Largest Percent Increase Since May 2020 -- Data Talk
- Donnelley Financial Solutions Reports Higher Q3 Adjusted Earnings, Net Sales; Shares Rise
- US Natural Gas Stocks Posts Larger Increase Than Expected in Week Ended Oct. 23
- Yubico Announces Q3 2026 Results Presentation
- GME Flashes TD Sequential Buy Signal — $22.60 Is the Line That Matters
- Bank of England opens consultation on tokenized collateral for clearing
- Ripple Eyes Moving Part of $16 Trillion In XRP
- Perella Weinberg Partners Shares Rise After Q3 Beat
- C.H. ROBINSON WORLDWIDE, INC. <CHRW.O>: BAIRD CUTS TARGET PRICE TO $175 FROM $200
- Bausch Health Surges on 3Q Beats, Rosier FY Outlook
- Market Chatter: HSBC in Talks With Insurers to Offload Data Center Loan Risk
- BUZZ - Cognizant lowers its full-year revenue forecast, shares fall
- Updated Version 3 - Revised Draft - Amid the AI spending boom, investors redraw boundaries, and cash is king
- Medical Facilities Corporation published an update to their financial calendar
- Carlyle to Sell Majority Stake in Wyyerd to Oak Hill Capital
- WEC Energy Group on Track for Largest Percent Increase Since December 2023 -- Data Talk
- Oxford Economics says U.S. economic growth is increasingly reliant on corporate investment
- Kvika Hosts Q3 Results Presentation for Investors
- Nordecon unit Eurocon Ukraine signs UAH 259.5 million warehouse construction contracts
- Dana Participates in Gabelli 50th Annual Automotive Symposium
- Dow Jones 10:30 AM Averages
- --US Natural Gas Stocks Rise by 80 Bln Cubic Feet in Week Ended Oct. 23 Vs. Expected 72 Bln Increase; Prior Gain of 77 Bln
- Pagaya Technologies Shares Rise After Q3 Non-GAAP Earnings, Revenue Increase
- S&P/TSX Composite Index Edges Lower Mid-Morning as Base Metal Shares Post Biggest Decline
- Supreme Court Rejects Bank DKI's Review Petition in Waskita Beton Precast Case
- Carvana Up Over 16%, on Pace for Largest Percent Increase Since July 2025 -- Data Talk
- Perrigo to Divest Infant Formula Business in $175 Million Deal
- Fortinet Stock Heads for Record Two-Day Rout. A Key Revenue Driver May Be to Blame. -- Barrons.com
- Graham Shares Decline Despite Higher Q3 Adjusted Net Income, Operating Revenue
- Newmark Shares Lower After Q3 Results, Outlook Lowered
- MercadoLibre publishes update to financial calendar
- Peoples 3Q EPS $1.82 >PPLL
- Bandwidth Shares Rise After Q3 Non-GAAP EPS, Revenue Beat Consensus
- Merck: 2026 Adj EPS Updated Outlook Includes One-Time Chgs of $3.62/Shr for Acquisition of Cidara, $2.31/Shr for Acquisition of Terns and 12c/Shr Related to Global License Agreement With SciBrunch >MRK
- Merck: 3Q Januvia/Janumet Sales Fell Primarily Driven by Lower Demand Due to Generic Competition Following Loss of Market Exclusivity in U.S. >MRK
- Merck: 3Q Animal Health Sales Growth Attributable to Both Livestock and Companion Animal Product Portfolios >MRK
- Merck: Latest 3Q Includes One-Time Charge of 12c/Shr Related to Global License Agreement With SciBrunch >MRK
- PBF Energy 3Q Rev $12.13B >PBF
- Merck 3Q Winrevair Sales $694M, Up 93%, Reflecting Higher Demand and Favorable Wholesaler and Specialty Pharmacy Purchasing Patterns in U.S. and Launch Uptake in Certain Intl Markets, Particularly in Europe and Japan >MRK
- Merck: 3Q Prevymis Sales $347M, Up 30%, Primarily Due to Higher Demand Globally >MRK
- Merck Adjusts 2026 View To Sales $66.8B-$67.3B Vs Prior View $66.3B-$67.3B >MRK
- Merck: Sales Outlook Includes Positive Impact From Forex of About 1% at Mid-October 2026 Exchange Rates >MRK
- Merck: 3Q Gardasil/Gardasil 9 Sales Rose Primarily Due to Higher Sales in U.S. Reflecting Favorable Public-Sector Purchasing Patterns and Higher Net Pricing >MRK
- Merck: Charge Related to SciBrunch Was Not Previously Included in Outlook >MRK
- Merck: Adj EPS Outlook Includes Positive Impact From Foreign Exchange of About 15c/Share at mid-October 2026 Exchange Rates >MRK
- BorgWarner 3Q Net $221M >BWA
- BorgWarner Sees FY Adj EPS $5.20-Adj EPS $5.35 >BWA
- BorgWarner Sees FY EPS $4.65-EPS $4.84 >BWA
- BorgWarner 3Q EPS $1.08 >BWA
- Merck 3Q Keytruda Sales $8.6B >MRK
- Merck 3Q Januvia/Janumet Sales $380M >MRK
- Merck 3Q Gardasil/Gardasil 9 Sales Up 14% >MRK
- Merck 3Q Pharmaceutical Sales Up 4% >MRK
- Merck 3Q Animal Health Sales $1.68B >MRK
- Caterpillar 3Q Resource Industries Sales Up 15% >CAT
- Caterpillar 3Q Resource Industries Sales $4.62B >CAT
- Merck 3Q EPS $2.04 >MRK
- Merck 3Q Pharmaceutical Sales $16.27B >MRK
- Merck 3Q Gardasil/Gardasil 9 Sales $2B >MRK
- Merck 3Q Animal Health Sales Up 4% >MRK
- Merck 3Q Keytruda Sales Up 6% >MRK
- Merck 3Q Sales $18.09B >MRK
- Merck 3Q Adj EPS $2.49 >MRK
- Merck Raises 2026 View To Adj EPS $2.77-Adj EPS $2.82 Vs Prior View $2.66-$2.76 >MRK
- L3Harris Technologies 3Q Orders $19.3B, Book-To-Bill 3.2x >LHX
- L3Harris Technologies 3Q-End Backlog $53.2B >LHX
